Tarsus Pharmaceuticals (TARS) Earnings Date & Reports

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TARS is expected to report earnings to rise 19.33% to -71 cents per share on May 13

Tarsus Pharmaceuticals TARS Stock Earnings Reports

Q1'25

Est.

$-0.72

Q4'24

Beat

by $0.17

Q3'24

Beat

by $0.33

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.17

The last earnings report on February 25 showed earnings per share of -60 cents, beating the estimate of -76 cents. With 625.27K shares outstanding, the current market capitalization sits at 1.78B.

View a ticker or compare two or three

Compare

TARS